Y.-Q. Deng et al. / Tetrahedron: Asymmetry 23 (2012) 1647–1652
1651
131.3, 127.2, 122.5, 118.3, 115.1, 105.5, 73.6, 58.6, 49.6, 49.1,
39.5, 34.2, 27.7, 26.0, 22.8, 18.9, 18.8.
5:95, flow rate 1.0 mL/min, UV detection at 208 nm, tmajor
(2R,3R) = 32.5 min, tminor (2S,3S) = 35.4 min.
4.2.4. (R)-(6-Hydroxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinu-
clidin-2-yl)methyl acetate Q-526
4.3.2. (2R,3R)-1,3-Dinitro-2-(4-bromophenyl)butane 10ab12
½
a 2D0
ꢂ
¼ þ8:5 (c 1.13, CH2Cl2). 1H NMR (400 MHz, CDCl3): d 7.50
Q-5 was prepared from O-acetylquinine27 according to the liter-
(d, J = 8.4 Hz, 2H), 7.04 (d, J = 8.4 Hz, 2H), 4.98–4.86 (m, 2H), 4.79
(dd, J = 8.4, 13.6 Hz, 1H), 3.99 (dd, J = 6.3, 14.5 Hz, 1H), 1.59 (d,
J = 6.7 Hz, 3H). 13C NMR (100 MHz, CDCl3): d 132.5, 129.6, 123.3,
83.9, 76.0, 46.9, 16.8. HPLC conditions: Daicel Chiralcel OD-H, i-
PrOH/hexane 30:70, flow rate 0.8 mL/min, UV detection at
208 nm, tmajor (2R,3R) = 16.8 min, tminor (2S,3S) = 36.9 min.
ature procedure and similar to QD-2, white solid, 58% yield. 1H
NMR (400 MHz, CDCl3):
d 8.67 (d, J = 4.5 Hz, 1H), 7.97 (d,
J = 9.2 Hz, 1H), 7.55 (d, J = 2.6 Hz, 1H), 7.34–7.25 (m, 2H), 6.57 (d,
J = 5.7 Hz, 1H), 6.05–5.96 (m, 2H), 5.13–5.08 (m, 2H), 3.34–3.26
(m, 1H), 3.05–2.91 (m, 2H), 2.83–2.69 (m, 2H), 2.32–2.26 (m,
1H), 2.12 (s, 3H), 1.98–1.85 (m, 1H), 1.82 (s, 1H), 1.57–1.45 (m,
2H), 1.40–1.32 (m, 1H).
4.3.3. (2R,3R)-1,3-Dinitro-2-(2-chlorophenyl)butane 10ac12
½
a 2D0
ꢂ
¼ þ12:0 (c 1.12, CH2Cl2). 1H NMR (400 MHz, CDCl3): d
4.2.5. (R)-(6-Hydroxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinu-
clidin-2-yl)methyl benzoate Q-626,29
7.46–7.40 (m, 1H), 7.26–7.13 (m, 3H), 5.18–5.06 (m, 1H), 4.89
(dd, J = 1.2, 6.8 Hz, 2H), 4.75–4.67 (m, 1H), 1.59 (d, J = 6.8 Hz, 3H).
13C NMR (100 MHz, CDCl3): d 134.5, 132.0, 130.8, 130.2, 128.0,
127.8, 84.1, 75.3, 43.1, 16.3. HPLC conditions: Daicel Chiralpak
AD-H, i-PrOH/hexane 2:98, flow rate 0.5 mL/min, UV detection at
208 nm, tmajor (2R,3R) = 45.1 min, tminor (2S,3S) = 47.9 min.
Q-6 was prepared from O-benzoylquinine according to the liter-
ature procedure; white solid, 70% yield. 1H NMR (400 MHz, CDCl3):
d 8.66 (d, J = 4.5 Hz, 1H), 8.11 (d, J = 7.1 Hz, 1H), 8.00 (d, J = 9.1 Hz,
1H), 7.72 (d, J = 2.5 Hz, 1H), 7.61 (t, J = 7.4 Hz, 1H), 7.49 (t,
J = 7.7 Hz, 2H), 7.36 (d, J = 4.5 Hz, 1H), 7.31 (dd, J = 2.5, 9.1 Hz,
1H), 6.87 (d, J = 4.0 Hz, 1H), 5.75 (ddd, J = 7.5, 10.3, 17.4 Hz, 1H),
5.02–4.92 (m, 2H), 3.44–3.34 (m, 1H), 3.30–3.20 (m, 1H), 3.13
(dd, J = 10.3, 13.7 Hz, 2H), 2.78–2.62 (m, 3H), 2.38–2.28 (m, 1H),
1.96–1.90 (m, 2H), 1.86–1.71 (m, 2H), 1.66–1.56 (m, 1H).
4.3.4. (2R,3R)-1,3-Dinitro-2-(3-chlorophenyl)butane 10ad12
½
a 2D0
ꢂ
¼ þ8:0 (c 0.20, CH2Cl2). 1H NMR (400 MHz, CDCl3): d 7.32–
7.30 (m, 2H), 7.17 (s, 1H), 7.05 (d, J = 7.3 Hz, 1H), 4.96–4.88 (m, 2H),
4.83–4.80 (m, 1H), 4.01 (dd, J = 6.4, 14.5 Hz, 1H), 1.60 (d, J = 6.8 Hz,
3H). 13C NMR (100 MHz, CDCl3): d 135.7, 135.1, 130.6, 129.4, 128.4,
126.0, 83.9, 75.8, 46.9, 16.8. HPLC conditions: Daicel Chiralpak AS-
H, i-PrOH/hexane 10:90, flow rate 1.0 mL/min, UV detection at
208 nm, tmajor (2R,3R) = 25.7 min, tminor (2S,3S) = 30.0 min.
4.2.6. (S)-1-Benzhydryl-3-(4-((S)-benzyloxy((2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)quinolin-6-yl)thiourea QD-730
Under nitrogen at room temperature, O-benzyl-6-aminoquini-
dine31,32 (400 mg, 1 mmol) was dissolved in THF (10 mL),
after which 3,5-bis(trifluoromethyl)phenyl isothiocyanate (298 mg,
1.1 mmol) was added into the solvent, and stirred for 24 h. The
solvent was removed under reduced atmosphere and then puri-
fied by column chromatography (ethyl acetate/methanol/triethyl-
amine 80:1:1, V/V/V) to give QD-7 as a colorless solid (396 mg,
62% yield). 1H NMR (400 MHz, CDCl3): d 8.84 (d, J = 4.4 Hz,
1H), 8.18 (s, 1H), 8.11 (d, J = 9.0 Hz, 1H), 7.66 (d, J = 7.5 Hz,
1H), 7.42 (s, 1H), 7.23–7.34 (m, 15H), 6.79–6.89 (m, 2H), 5.86
(m, 1H), 5.03 (br s, 1H), 4.99 (s, 1H), 4.96 (d, J = 5.3 Hz, 1H),
4.31 (d, J = 11.6 Hz, 1H), 4.16 (d, J = 11.5 Hz, 1H), 3.74 (t,
J = 6.5 Hz, 1H), 3.09 (s, 1H), 3.00 (s, 1H), 2.69–2.77 (m, 2H),
2.54–2.62 (m, 1H), 1.93 (s, 1H), 1.81–1.88 (m, 1H), 1.73 (s,
1H), 1.43–1.47 (m, 3H). 13C NMR (100 MHz, CDCl3): d 180.6,
149.6, 146.4, 146.3, 141.0, 140.4, 137.5, 131.3, 128.8, 128.4,
127.9, 127.8, 127.7, 127.6, 126.9, 126.5, 114.6, 71.3, 68.0, 62.0,
60.1, 49.8, 39.9, 28.0, 26.3, 25.6. HRMS (ESI-TOF): m/z calcd for
4.3.5. (2R,3R)-1,3-Dinitro-2-(4-chlorophenyl)butane 10ae11
½
a 2D0
ꢂ
¼ þ10:2 (c 1.02, CH2Cl2). 1H NMR (400 MHz, CDCl3): d
7.37–7.32 (m, 2H), 7.10 (d, J = 8.5 Hz, 2H), 4.98–4.85 (m, 2H),
4.79 (dd, J = 8.5, 13.6 Hz, 1H), 4.00 (dt, J = 6.3, 8.2 Hz, 1H), 1.59 (d,
J = 6.7 Hz, 3H). 13C NMR (100 MHz, CDCl3): d 135.3, 131.9, 129.6,
129.3, 83.9, 76.0, 46.9, 16.8. HPLC conditions: Daicel Chiralcel
OD-H, i-PrOH/hexane 30:70, flow rate 0.8 mL/min, UV detection
at 208 nm, tmajor (2R,3R) = 15.7 min, tminor (2S,3S) = 26.9 min.
4.3.6. (2R,3R)-1,3-Dinitro-2-(2-fluorophenyl)butane 10af11
½
a 2D0
ꢂ
¼ þ20:2 (c 1.05, CH2Cl2). 1H NMR (400 MHz, CDCl3): d
7.35–7.32 (m, 1H), 7.13–7.10 (m, 3H), 5.08–5.04 (m, 1H), 4.94–
4.82 (m, 2H), 4.32 (dd, J = 7.2, 14.3 Hz, 1H), 1.62 (d, J = 6.7 Hz,
3H). 13C NMR (100 MHz, CDCl3): d 131.0, 130.9, 129.7, 129.6,
125.0, 120.9, 120.8, 116.4, 116.2, 83.3, 75.1, 42.1, 17.0. HPLC condi-
tions: Daicel Chiralcel OD-H, i-PrOH/hexane 20:80, flow rate
0.8 mL/min, UV detection at 208 nm, tmajor (2R,3R) = 17.3 min, tmi-
C
40H40N4OS [M+H]+ 625.3001; found: 625.3000.
(2S,3S) = 28.8 min.
nor
4.3. Typical procedure for the Michael addition reaction
4.3.7. (2R,3R)-1,3-Dinitro-2-(3-fluorophenyl)butane 10ag
Nitroethane 8a (2.2 mL, 30 mmol) was added to a vial contain-
ing catalyst QD-2 (7 mg, 0.02 mmol) and trans-b-nitrostyrene 9a
(149 mg, 1 mmol) at 30 °C. TLC analysis indicated the completion
of the reaction. The reaction mixture was concentrated under vac-
uum. The dr value was determined by 1H NMR analysis of the res-
idue, which was then purified by flash silica gel chromatography
(ethyl acetate/hexane = 1:20 to 1:10) to afford the adduct syn-
10aa (125 mg, 0.56 mmol) as a white solid and anti-10aa (62 mg,
0.28 mmol) as a clear oil in 85% total yield.
½
a 2D0
ꢂ
¼ þ20:0 (c 1.05, CH2Cl2). 1H NMR (400 MHz, CDCl3): d
7.40–7.34 (m, 1H), 7.09–6.93 (m, 3H), 4.87–4.78 (m, 2H), 4.70–
4.65(m, 1H), 4.07–4.01 (m, 1H), 1.44 (d, J = 6.8 Hz, 3H). 13C NMR
(100 MHz, CDCl3): d 164.1, 161.7, 136.1, 131.0, 123.7, 116.2,
115.3, 84.0, 75.9, 47.0, 16.8. Daicel Chiralpak AS-H, i-PrOH/hexane
10:90, flow rate 1.0 mL/min, UV detection at 208 nm, tmajor
(2R,3R) = 24.0 min, tminor (2S,3S) = 27.1 min.
4.3.8. (2R,3R)-1,3-Dinitro-2-(4-fluorophenyl)butane 10ah11
½
a 2D0
ꢂ
¼ þ7:3 (c 0.87, CH2Cl2). 1H NMR (400 MHz, CDCl3): d 7.16–
4.3.1. (2R,3R)-1,3-Dinitro-2-phenylbutane 10aa11
7.13 (m, 2H), 7.08–7.03 (m, 2H), 4.99–4.86 (m, 2H), 4.79 (dd, J = 8.4,
13.6 Hz, 1H), 4.01 (dd, J = 6.3, 14.5 Hz, 1H), 1.60 (d, J = 6.7 Hz, 3H).
13C NMR (100 MHz, CDCl3): d 129.8, 116.5, 116.3, 84.0, 76.2, 46.8,
16.8. HPLC conditions: Daicel Chiralcel OD-H, i-PrOH/hexane
30:70, flow rate 0.8 mL/min, UV detection at 208 nm, tmajor
(2R,3R) = 14.0 min, tminor (2S,3S) = 17.2 min.
½
a 2D0
ꢂ
¼ þ4:9 (c 0.8, CH2Cl2). 1H NMR (400 MHz, CDCl3): d 7.37–
7.32 (m, 3H), 7.17–7.14 (m, 2H), 5.00–4.90 (m, 2H), 4.84–4.79
(m, 1H), 4.05–4.00 (m, 1H), 1.58 (d, J = 6.8 Hz, 3H). 13C NMR
(100 MHz, CDCl3): d 133.5, 129.3, 129.1, 128.0, 84.0, 76.1, 47.4,
16.7. HPLC conditions: Daicel Chiralpak AS-H, i-PrOH/hexane